United States Next-Generation Biomanufacturing Market By Type (Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, Downstream Biomanufacturing), By Medical Application (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Others), By End Users (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutions), By Region, Forecast & Opportunities, 2027

United States next-generation biomanufacturing market is anticipated to witness significant growth during the forecast period owing to

Moreover, the

United States next-generation biomanufacturing market is categorized based on type, medical application, end users and region.

Based on end users, the United States next-generation biomanufacturing market can be segmented into biopharmaceutical companies, CMOs/CDMOs and research institutions. Among them, biopharmaceutical companies are expected to contribute to major share of revenue the United States next-generation biomanufacturing market during the forecast period owing to higher number of biopharmaceutical companies and increasing adoption of advanced healthcare technologies.

Major players operating in the United States next-generation biomanufacturing market include Thermo Fisher Scientific, Inc., Danaher Corporation, Merck & Co., Inc., Eppendorf, Inc., Sartorius Corporation, GEA North America, Inc., PBS Biotech, Inc, Applikon Biotechnology, Inc. and Meissner Filtration Products, Inc., among others. The market players are undergoing growth strategies like strategic partnerships and strategic collaborations & partnerships.

Objective of the Study

• To analyze and estimate the market size of United States next-generation biomanufacturing market from 2017 to 2020.
• To estimate and forecast the market size of United States next-generation biomanufacturing market from 2021 to 2027 and growth rate until 2027.
• to classify and forecast United States next-generation biomanufacturing market based on type, medical application, end users, company and regional distribution.
• To identify dominant region or segment in the United States next-generation biomanufacturing market.
• To identify drivers and challenges for United States next-generation biomanufacturing market.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States next-generation biomanufacturing market.
• To conduct pricing analysis for United States next-generation biomanufacturing market.
• To identify and analyze the profile of leading players operating in United States next-generation biomanufacturing market.
• To identify key sustainable strategies adopted by market players in United States next-generation biomanufacturing market.

Click here to download the sample

Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of next-generation biomanufacturing companies across United States. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the companies who could not be identified due to the limitations of secondary research. Market insights research analyzed the presence of all major players across the countries.

Market insights research calculated the market size of

Key Target Audience

• Next-generation biomanufacturing manufactures, suppliers, distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to next-generation biomanufacturing
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as next-generation biomanufacturing manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.